NCT05484622
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05484622
Title Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive Enhancing IDH-1 Mutant Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Institut de Recherches Internationales Servier
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
University of California, Los Angeles (Site: 840113) Los Angeles California 90095 United States Details
University of California, San Francisco (Site: 840149) San Francisco California 94013 United States Details
University of Colorado Aurora Colorado 80045 United States Details
University of Miami (Site: 840129) Miami Florida 33136 United States Details
Northwestern University (Site: 840123) Chicago Illinois 60045 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Massachusetts General Hospital (Site: 840104) Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute (Site: 840139) Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Memorial Sloan Kettering Cancer Center (Site: 840117) New York New York 10017 United States Details
Duke University (Site: 840110) Durham North Carolina 27705 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Mayo Clinic Florida Cleveland Ohio 44195 United States Details
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center (Site: 840102) Houston Texas 77030 United States Details
University of Utah, Huntsman Cancer Center Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field